Montreal, Canada

Olivier Nicolas

This inventor holds 4 USPTO granted patents and 3 published patent applications. Top assignee: Vertex Pharmaceuticals, Inc.. Active years: 2023-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Olivier Nicolas. Retrieved from https://idiyas.com/inventor/olivier-nicolas-v6051h4b

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank
USPTO Granted Patents = 4 

% Patents Active = 100.0

Average Co-Inventor Count = 20.4

ph-index = 1

Forward Citations = 5(Granted Patents)


Company Filing History:


Years Active: 2023-2025

Loading Chart...
4 patents (USPTO):Explore Patents

Title: Biography of Inventor Olivier Nicolas

Introduction: Olivier Nicolas is a prominent inventor based in Montreal, Canada. He has made significant contributions to the field of pharmaceuticals, particularly in the development of treatments for kidney diseases.

Latest Patents: Olivier holds four patents, with his latest focusing on inhibitors of APOL1 and methods of using the same. This patent discloses at least one compound, deuterated derivative, or pharmaceutically acceptable salt chosen from compounds of formula (I), deuterated derivatives thereof, and pharmaceutically acceptable salts of any of the foregoing. The compositions and methods described include applications in treating APOL1 mediated kidney disease.

Career Highlights: Olivier is currently employed at Vertex Pharmaceuticals, Inc., where he continues to innovate and develop new therapeutic solutions. His work has been instrumental in advancing the understanding and treatment of kidney-related conditions.

Collaborations: Throughout his career, Olivier has collaborated with notable colleagues, including Jingrong Cao and Jon H Come. These partnerships have fostered a collaborative environment that enhances research and development efforts.

Conclusion: Olivier Nicolas is a dedicated inventor whose work is making a difference in the medical field. His innovative patents and collaborations reflect his commitment to improving health outcomes for patients suffering from kidney diseases.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…